报价延迟最少15分钟:2026/04/26 08:32 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
16.8 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.66/-0.72
|
|
企业价值
641.46M
|
| 资产负债 |
|
每股账面净值
0.56
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
99.99M
|
|
每股收益
1.77
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads,depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care. |
